Development of autologous T lymphocytes in two males with X-linked severe combined immune deficiency: Molecular and cellular characterization

Clinical Immunology

Volumn 95, Issue 1 I, 2000, Pages 39-50

  Mella, Patrizia ^a   Imberti, Luisa ^a   Brugnoni, Duilio ^b   Pirovano, Silvia ^a   Candotti, Fabio ^a   Mazzolari, Evelina ^a   Bettinardi, Alessandra ^b   Fiorini, Maurilia ^a   De Mattia, Domenico ^c   Martire, Baldassarre ^c   Plebani, Alessandro ^a   Notarangelo, Luigi D ^a   Giliani, Silvia ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SPEDALI CIVILI   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Common chain; Interleukin receptor; Severe combined immune deficiency; T lymphocyte; T cell repertoire

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE RECEPTOR; INTERLEUKIN 2 RECEPTOR; RNA; STAT5 PROTEIN;

ADOLESCENT; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; COMBINED IMMUNODEFICIENCY; GENE MUTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOGENETICS; INFANT; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; X CHROMOSOME LINKAGE; X CHROMOSOME LINKED DISORDER;

EID: 0034036469     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4842     Document Type: Article

References (42)

1. Stephan, J. L., Vlekova, V., Le Deist, F., Blanche, S., Donadieu, J., De Saint-Basile, G., Durandy, A., Griscelli, C., and Fischer, A., Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patients. J. Pediatr. 123, 564-572, 1993.
2. Buckley, R. H., Schiff, R. I., Schiff, S. E., Markert, M. L., Williams, L. W., Harville, T. O., Roberts, J. L., and Puck, J. M., Human severe combined immunodeficiency: Genetic, phenotypic, and functional diversity in one hundred eight infants. J. Pediatr. 130, 378-387, 1997.
3. c. Immunol. Rev. 138, 61-86, 1994.
4. c-chain defects causing human X-SCID. Immunol. Today 17, 507-511, 1996.
5. O'Shea, J. J., Notarangelo, L. D., Johnston, J. A., and Candotti, F., Advances in the understanding of cytokine signal transduction: The role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency. J. Clin. Immunol. 17, 431-447, 1997.
6. Macchi, P., Villa, A., Giliani, S., Sacco, M. G., Frattini, A., Porta, F., Ugazio, A. G., Johnston, J. A., Candotti, F., O'Shea, J. J., Vezzoni, P., and Notarangelo, L. D., Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377, 65-68, 1995.
7. Russell, S. M., Tayebi, N., Nakajima, H., Riedy, M. C., Roberts, J. L., Aman, M. J., Migone, T.-S., Noguchi, M., Markert, M. L., Buckley, R. H., O'Shea, J. J., and Leonard, W. J., Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development. Science 70, 797-800, 1995.
8. Sharfe, N., Shahar, M., and Roifman, C. M., An Interleukin-2 receptor γ chain mutation with normal thymus morphology. J. Clin. Invest. 100, 3036-3043, 1997.
9. Di Santo, J. P., Rieuz-Laucat, F., Dautry-Varsat, A., Fischer, A., and De Saint Basile, G., Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells. Proc. Natl. Acad. Sci. USA 91, 9466-9470, 1994.
10. Schmalstieg, F. C., Leonard, W. J., Noguchi, M., Berg, M., Rudloff, H. E., Denney, R. M., Dave, S. K., Brooks, E. G., and Goldman, A. S., Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency. J. Clin. Invest. 95, 1169-1173, 1995.
11. Stephan, V., Wahn, V., Le Deist, F., Dirksen, U., Broeker, B., Mueller-Fleckenstein, I., Horneff, G., Schroten, H., Fischer, A., and De Saint Basile, G., Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N. Engl. J. Med. 335, 1563-1567, 1996.
12. c chain in a severe combined immune deficiency X1 patient. Blood 88, 1708-1717, 1996.
13. Brugnoni, D., Airò, P., Facchetti, F., Blanzuoli, L., Ugazio, A. G., Cattaneo, R., and Notarangelo, L. D., In vitro cell death of activated lymphocytes in Omenn's syndrome. Eur. J. Immunol. 27, 1-9, 1997.
14. Bettinardi, A., Brugnoni, D., Quiròs-Roldan, E., Malagoli, A., La Grutta, S., Correra, A., and Notarangelo, L. D., Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: A molecular and immunological analysis. Blood 89, 902-909, 1997.
15. Candotti, F., Oakes, S. A., Johnston, J. A., Giliani, S., Schumacher, R. F., Mella, P., Fiorini, M., Ugazio, A. G., Badolato, R., Notarangelo, L. D., Bozzi, F., Macchi, P., Strina, D., Vezzoni, P., Blease, R. M., O'Shea, J. J., and Villa, A., Structural and functional basis for JAK3-deficient severe combined immunodeficiency. Blood 90, 3996-4003, 1997.
16. Wengler, G. S., Giliani, S., Fiorini, M., Mella, P., Mantuano, E., Zanola, A., Pollonini, G., Eibl, M. M., Ugazio, A. G., Notarangelo, L. D., and Parolini, O., Mutation analysis by a non-radioactive single-strand conformation polymorphism assay in nine families with X-linked severe combined immunodeficiency (SCIDX1). Br. J. Haematol. 101, 586-591, 1998.
17. Martin, R., Howell, M. D., Jaraquemada, D., Flerlage, M., Richert, J., Brostoff, S., Long, E. O., McFarlin, D. E., and McFarland, H. F., A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J. Exp. Med. 173, 19-24, 1991.
18. Bettinardi, A., Imberti, L., Sottini, A., and Primi, D., Analysis of amplified T cell receptor V-β transcripts by a non-isotopic immunoassay. J. Immunol. Methods 146, 71-82, 1992.
19. Signorini, S., Imberti, L., Pirovano, S., Villa, A., Facchetti, F., Ungari, M., Bozzi, F., Albertini, A., Ugazio, A. G., Vezzoni, P., and Notarangelo, L. D., Intrathymic restriction and peripheral expansion of the T cell repertoire in Omenn syndrome. Blood 94, 3468-3478, 1999.
20. Tonoyaga, B., Yoshikai, Y., Vadasz, V., Chin, B., and Mak, T. W., Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor β chain. Proc. Natl. Acad. Sci. USA 82, 8624-8628, 1985.
21. Arden, B., Clark, S. P., Kabelitz, D., and Mak, T. W., Human T-cell receptor variable gene segment families. Immunogenetics 42, 455-500, 1995.
22. Sottini, A., Quiròs-Roldan, E., Albertini, A., Primi, D., and Imberti, L., Assessment of T cell receptor variable beta chains diversity by heteroduplex analysis. Hum. Immunol. 48, 12-22, 1996.
23. Jones, A. M., Clark, P. A., Katz, F., Genet, S., McMahon, C., Alterman, L., Cant, A., and Kinnon, C., B-cell-negative severe combined immunodeficiency associated with a common γ chain mutation. Hum. Genet. 99, 677-680, 1997.
24. Pepper, A. E., Buckley, R. H., Small, T. N., and Puck, J. M., Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency. Am. J. Hum. Genet. 57, 564-571, 1995.
25. Paschall, V. L., Brown, L. A., Lawrence, E. C., Karol, R. A., Lotzova, E., Brown, B. S., and Shearer, W. T., Immunoregulation in an isolated 12-year-old boy with congenital severe combined immunodeficiency. Pediatr. Res. 18, 723-728, 1984.
26. South, M. A., Montgomery, J. R., Richie, E., Mukhopadhyay, N., Criswell, B. S., Mackler, B. F., De Fazio, S. R., Bealmear, P., Heim, L. R., Trentin, J. J., Dressman, G. R., and O'Neill, P., A special report: Four-year study of a boy with combined immune deficiency maintained in strict reverse isolation from birth. IV. Immunologic studies. Pediatr. Res. 11, 71-78, 1977.
27. Shearer, W. T., Ritz, J., Finegold, M. J., Guerra, I. C., Rosenblatt, H. M., Lewis, D. E., Pollack, M. S., Taber, L. H., Sumaya, C. V., Grumet, F. C., Cleary, M. L., Warnke, R., and Sklar, J., Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. N. Engl. J. Med. 312, 1151-1159, 1985.
28. Brooks, E. G., Schmalstieg, F. C., Wirt, D. P., Rosenblatt, H. M., Adkins, L. T., Lookingbill, D. P., Rudloff, H. E., Rakusan, T. A., and Goldman, A. S., A novel X-linked combined immunodeficiency disease. J. Clin. Invest. 86, 1623-1631, 1990.
29. Schmalstieg, F. C., Wirt, D. P., Adkins, L. T., Brooks, E. G., Stansberry, S. D., Swischuk, L. E., and Goldman, A. S., Postnatal development of T lymphocytes in a novel X-linked immunodeficiency disease. Clin. Immunol. Immunopathol. 64, 71-77, 1992.
30. c chains with Jakl and Jak3: Implications for XSCID and XCID. Science 266, 1042-1045, 1994.
31. Brugnoni, D., Notarangelo, L. D., Sottini, A., Airò, P., Pennacchio, M., Mazzolari, E., Signorini, S., Candotti, F., Villa, A., Mella, P., Vezzoni, P., Cattaneo, R., Ugazio, A. G., and Imberti, L., Development of autologous, oligoclonal, poorly functioning T lymphocytes in a patient with autosomal recessive severe combined immunodeficiency caused by defects of the Jak3 tyrosine kinase. Blood 91, 949-955, 1998.
32. Von Freeden-Jeffry, U., Vieira, P., Lucian, L. A., McNeil, T., Burdach, S. E. G., and Murray, R., Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181, 1519-1526, 1995.
33. Peschon, J. J., Morrissey, P. J., Grabstein, K. H., Ramsdell, F. J., Maraskovsky, E., Gliniak, B. C., Park, L. S., Ziegler, S. F., Williams, D. E., Ware, C. B., Meyer, J. D., and Davison, B. L., Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955-1960, 1994.
34. + severe combined immunodeficiency. Nat. Genet. 20, 394-397, 1998.
35. Kündig, T. M., Schorle, H., Bachmann, M. F., Hengartner, H., Zinkernagel, R. M., and Horak, I., Immune responses in interleukin-2-deficient mice. Science 262, 1059-1061, 1993.
36. Schorle, H., Holtschke, T., Hünig, T., Schimpl, A., and Horak, I., Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352, 621-624, 1991.
37. Pahwa, R., Chatila, T., Pahwa, S., Paradise, C., Day, N. K., Geha, R., Schwartz, S. A., Slade, H., Oyaizu, N., and Good, R. A., Recombinant interleukin 2 therapy in severe combined immunodeficiency disease. Proc. Natl. Acad. Sci. USA 86, 5069-5073, 1989.
38. Sharfe, N., Dadi, H. K., Shahar, M., and Roifman, C. M., Human immune disorder arising from mutation of the a chain of the interleukin-2 receptor. Proc. Natl. Acad. Sci. USA 94, 3168-3171, 1997.
39. Puck, J. M., Pepper, A. E., Henthorn, P. S., Candotti, F., Isakov, J., Whitwam, T., Conley, M. E., Fischer, R. E., Rosenblatt, H. M., Small, T. N., and Buckley, R. H., Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood 89, 1968-1977, 1997.
40. Bamborough, P., Hedgecock, C., Jr., and Richards, W. G., The interleukin-2 and interleukin-4 receptors studied by molecular modelling. Structure 2, 839-851, 1994.
41. Brown, M. P., Nosaka, T., Tripp, R. A., Brooks, J., van Deursen, J. M. A., Brenner, M. K., Doherty, P. C., and Ihle, J. N., Reconstitution of early lymphoid proliferation and immune function in Jak3-deficient mice by interleukin-3. Blood 94, 1906-1914, 1999.
42. Kumaki, S., Ishii, N., Minegishi, M., Tsuchiya, S., Cosman, D., Sugamura, K., and Konno, T., Functional role of interleukin-4 (IL-4) and IL-7 in the development of X-linked severe combined immunodeficiency. Blood 93, 607-612, 1999.